Skip to main content

Supportive Care in Cancer

Ausgabe 11/2015

Inhalt (29 Artikel)

Original Article

Women’s experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour

Caitriona Cahir, Stephan U. Dombrowski, Catherine M. Kelly, M. John Kennedy, Kathleen Bennett, Linda Sharp

Original Article

Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation

Diana T. Nguyen, Sepideh Shayani, Joycelynne Palmer, Andrew Dagis, Stephen J. Forman, Joel Epstein, Ricardo Spielberger

Original Article

Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan–prognostic assessment tools validation (J-ProVal) study

Tomofumi Miura, Yoshihisa Matsumoto, Takashi Hama, Koji Amano, Yo Tei, Ayako Kikuchi, Akihiko Suga, Takayuki Hisanaga, Tatsuhiko Ishihara, Mutsumi Abe, Keisuke Kaneishi, Shohei Kawagoe, Toshiyuki Kuriyama, Takashi Maeda, Ichiro Mori, Nobuhisa Nakajima, Tomohiro Nishi, Hiroki Sakurai, Tatsuya Morita, Hiroya Kinoshita

Original Article

Palliative care in patients with ovarian cancer and bowel obstruction

Alberto Daniele, A. Ferrero, L. Fuso, M. Mineccia, V. Porcellana, D. Vassallo, N. Biglia, G. Menato

Original Article

Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study

J. M. Bowen, I. White, L. Smith, A. Tsykin, K. Kristaly, S. K. Thompson, C. S. Karapetis, H. Tan, P. A. Game, T. Irvine, D. J. Hussey, D. I. Watson, D. M. K. Keefe

Original Article

Evaluating the Liverpool Care Pathway for care of the terminally ill in rural Australia

Anne M. Wilkinson, Claire E. Johnson, Helen Walker, Valerie Colgan, Hayley Arnet, Tapan Rai

Original Article

Chemotherapy interruptions in relation to symptom severity in advanced breast cancer

Gwen Wyatt, Alla Sikorskii, Irena Tesnjak, David Victorson, Gordan Srkalovic

Original Article

Follow-up care practices and barriers to breast cancer survivorship: perspectives from Asian oncology practitioners

Terence Ng, Ming Ren Toh, Yin Ting Cheung, Alexandre Chan

Original Article

Disparities in barriers to follow-up care between African American and White breast cancer survivors

Nynikka R. A. Palmer, Kathryn E. Weaver, Sally P. Hauser, Julia A. Lawrence, Jennifer Talton, L. Douglas Case, Ann M. Geiger

Original Article

Potential factors associated with perceived cognitive impairment in breast cancer survivors

Jamie S. Myers, Jo A. Wick, Jennifer Klemp

Original Article

Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial

Sameer Bakhshi, Atul Batra, Bivas Biswas, Deepa Dhawan, Reeja Paul, Vishnubhatla Sreenivas

Original Article

Exercise preferences, levels and quality of life in lung cancer survivors

H. J. Leach, J. A. Devonish, D. G. Bebb, K. A. Krenz, S. N. Culos-Reed

Original Article

Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients

Sebastiano Mercadante, Federica Aielli, Claudio Adile, Patrizia Ferrera, Alessandro Valle, Flavio Fusco, Amanda Caruselli, Claudio Cartoni, Pizzuto Massimo, Francesco Masedu, Marco Valenti, Giampiero Porzio

Original Article

The eating experience in long-term survivors of head and neck cancer: a mixed-methods study

Heidi Ganzer, Pamela Rothpletz-Puglia, Laura Byham-Gray, Barbara A. Murphy, Riva Touger-Decker

Original Article

Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy—a survey of health care providers and patients

Carmel Jacobs, Brian Hutton, Sasha Mazzarello, Stephanie Smith, Anil Joy, Eitan Amir, Mohammed F. K. Ibrahim, Nancy Gregario, Kelly Daigle, Lori Eggert, Mark Clemons

Original Article

Chemotherapy in the last 30 days of life of advanced cancer patients

Paola Pacetti, Giovanni Paganini, Massimo Orlandi, Andrea Mambrini, M. Cristina Pennucci, Alfonso Del Freo, Maurizio Cantore

Original Article

Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)

Salvatore Giacomo Morano, Roberto Latagliata, Corrado Girmenia, Fulvio Massaro, Paola Berneschi, Alfonso Guerriero, Massimo Giampaoletti, Arianna Sammarco, Giorgia Annechini, Angelo Fama, Alice Di Rocco, Antonio Chistolini, Alessandra Micozzi, Matteo Molica, Walter Barberi, Clara Minotti, Gregorio Antonio Brunetti, Massimo Breccia, Claudio Cartoni, Saveria Capria, Giovanni Rosa, Giuliana Alimena, Robin Foà

Open Access Original Article

Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey

Cheryl Vidall, Paz Fernández-Ortega, Diego Cortinovis, Patrick Jahn, Bharat Amlani, Florian Scotté

Original Article

A randomised phase IIb trial to assess the efficacy of ReCharge ice cream in preventing chemotherapy-induced diarrhoea

D. Perez, K. J. Sharples, R. Broom, M. Jeffery, J. Proctor, V. Hinder, S. Pollard, J. Edwards, A. Simpson, J. Scott, S. Benge, G. Krissansen, A. Geursen, K. Palmano, A. MacGibbon, D. Keefe, M. Findlay

Original Article

Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer

Kosei Kubota, Wataru Kobayashi, Hirotaka Sakaki, Hiroshi Nakagawa, Takao Kon, Mayu Mimura, Ryohei Ito, Ken Furudate, Hiroto Kimura

Original Article

Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool

Yuka Matsuda, Kenji Okita, Tomohisa Furuhata, Goro Kutomi, Kentaro Yamashita, Yasushi Sato, Rishu Takimoto, Koichi Hirata

Original Article

Defining optimal control of chemotherapy-induced nausea and vomiting—based on patients’ experience

Catalina Hernandez Torres, Sasha Mazzarello, Terry Ng, George Dranitsaris, Brian Hutton, Stephanie Smith, Amy Munro, Carmel Jacobs, Mark Clemons

Open Access Original Article

The course of fatigue and its correlates in colorectal cancer survivors: a prospective cohort study of the PROFILES registry

Olga Husson, Floortje Mols, Lonneke V. van de Poll-Franse, Melissa S. Y. Thong

Open Access Original Article

Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial

Janelle Yorke, Mari Lloyd-Williams, Jacky Smith, Fiona Blackhall, Amelie Harle, June Warden, Jackie Ellis, Mark Pilling, Jemma Haines, Karen Luker, Alex Molassiotis

Review Article

Pre-transplant arm muscle area: a simple measure to identify patients at risk

Ana Cláudia Thomaz, Carolline Ilha Silvério, Denise Johnsson Campos, Elena Emilia Moreira Kieuteka, Estela Iraci Rabito, Vaneuza Araújo Moreira Funke, Regina Maria Vilela

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.